Cargando…
Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors
Giant cell tumors of soft tissue (GCT-ST) are rare low-grade neoplasms that were at one time thought to represent the soft tissue counterparts of GCT of bone (GCT-B) but are now known to lack the H3F3 mutations characteristic of osseous GCT. We present six distinctive giant cell-rich soft tissue neo...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295036/ https://www.ncbi.nlm.nih.gov/pubmed/33742141 http://dx.doi.org/10.1038/s41379-021-00789-8 |
_version_ | 1783725357846757376 |
---|---|
author | Agaimy, Abbas Michal, Michael Stoehr, Robert Ferrazzi, Fulvia Fabian, Pavel Michal, Michal Franchi, Alessandro Haller, Florian Folpe, Andrew L. Kösemehmetoğlu, Kemal |
author_facet | Agaimy, Abbas Michal, Michael Stoehr, Robert Ferrazzi, Fulvia Fabian, Pavel Michal, Michal Franchi, Alessandro Haller, Florian Folpe, Andrew L. Kösemehmetoğlu, Kemal |
author_sort | Agaimy, Abbas |
collection | PubMed |
description | Giant cell tumors of soft tissue (GCT-ST) are rare low-grade neoplasms that were at one time thought to represent the soft tissue counterparts of GCT of bone (GCT-B) but are now known to lack the H3F3 mutations characteristic of osseous GCT. We present six distinctive giant cell-rich soft tissue neoplasms that expressed keratins and carried a recurrent HMGA2-NCOR2 gene fusion. Patients were five females and one male aged 14–60 years (median, 29). All presented with superficial (subcutaneous) masses that were removed by conservative marginal (3) or wide (2) local excision. The tumors originated in the upper extremity (2), lower extremity (2), head/neck (1), and trunk (1). Five patients with follow-up (median, 21 months; range, 14–168) remained disease-free. Grossly, all tumors were well-demarcated but not encapsulated with variable lobulation. Histologically, they were composed of bland plump epithelioid or ovoid to spindled mononuclear cells admixed with evenly distributed multinucleated osteoclast-type giant cells. Foci of stromal hemorrhage and hemosiderin were seen in all cases. The mitotic activity ranged from 2 to 14/10 high power fields (median: 10). Foci of necrosis and vascular invasion were seen in one case each. The mononuclear cells were immunoreactive with the AE1/AE3 keratin cocktail and less frequently/less diffusely for K7 and K19 but lacked expression of other lineage-associated markers. RNA-based next-generation sequencing revealed an HMGA2-NCOR2 fusion in all tumors. None of the keratin-negative conventional GCT-ST showed the HMGA2-NCOR2 fusion (0/7). Metaplastic bone (4/9) and SATB2 expression (3/4) were frequent in keratin-negative conventional GCT-ST but were lacking in keratin-positive HMGA2-NCOR2 fusion-positive tumors. The distinctive immunophenotype and genotype of these tumors strongly suggest that they represent a discrete entity, differing from conventional GCT-ST and other osteoclast-rich morphologic mimics. Their natural history appears favorable, although a study of additional cases and longer follow-up are warranted. |
format | Online Article Text |
id | pubmed-8295036 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-82950362021-08-05 Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors Agaimy, Abbas Michal, Michael Stoehr, Robert Ferrazzi, Fulvia Fabian, Pavel Michal, Michal Franchi, Alessandro Haller, Florian Folpe, Andrew L. Kösemehmetoğlu, Kemal Mod Pathol Article Giant cell tumors of soft tissue (GCT-ST) are rare low-grade neoplasms that were at one time thought to represent the soft tissue counterparts of GCT of bone (GCT-B) but are now known to lack the H3F3 mutations characteristic of osseous GCT. We present six distinctive giant cell-rich soft tissue neoplasms that expressed keratins and carried a recurrent HMGA2-NCOR2 gene fusion. Patients were five females and one male aged 14–60 years (median, 29). All presented with superficial (subcutaneous) masses that were removed by conservative marginal (3) or wide (2) local excision. The tumors originated in the upper extremity (2), lower extremity (2), head/neck (1), and trunk (1). Five patients with follow-up (median, 21 months; range, 14–168) remained disease-free. Grossly, all tumors were well-demarcated but not encapsulated with variable lobulation. Histologically, they were composed of bland plump epithelioid or ovoid to spindled mononuclear cells admixed with evenly distributed multinucleated osteoclast-type giant cells. Foci of stromal hemorrhage and hemosiderin were seen in all cases. The mitotic activity ranged from 2 to 14/10 high power fields (median: 10). Foci of necrosis and vascular invasion were seen in one case each. The mononuclear cells were immunoreactive with the AE1/AE3 keratin cocktail and less frequently/less diffusely for K7 and K19 but lacked expression of other lineage-associated markers. RNA-based next-generation sequencing revealed an HMGA2-NCOR2 fusion in all tumors. None of the keratin-negative conventional GCT-ST showed the HMGA2-NCOR2 fusion (0/7). Metaplastic bone (4/9) and SATB2 expression (3/4) were frequent in keratin-negative conventional GCT-ST but were lacking in keratin-positive HMGA2-NCOR2 fusion-positive tumors. The distinctive immunophenotype and genotype of these tumors strongly suggest that they represent a discrete entity, differing from conventional GCT-ST and other osteoclast-rich morphologic mimics. Their natural history appears favorable, although a study of additional cases and longer follow-up are warranted. Nature Publishing Group US 2021-03-19 2021 /pmc/articles/PMC8295036/ /pubmed/33742141 http://dx.doi.org/10.1038/s41379-021-00789-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Agaimy, Abbas Michal, Michael Stoehr, Robert Ferrazzi, Fulvia Fabian, Pavel Michal, Michal Franchi, Alessandro Haller, Florian Folpe, Andrew L. Kösemehmetoğlu, Kemal Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors |
title | Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors |
title_full | Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors |
title_fullStr | Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors |
title_full_unstemmed | Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors |
title_short | Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors |
title_sort | recurrent novel hmga2-ncor2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295036/ https://www.ncbi.nlm.nih.gov/pubmed/33742141 http://dx.doi.org/10.1038/s41379-021-00789-8 |
work_keys_str_mv | AT agaimyabbas recurrentnovelhmga2ncor2fusionscharacterizeasubsetofkeratinpositivegiantcellrichsofttissuetumors AT michalmichael recurrentnovelhmga2ncor2fusionscharacterizeasubsetofkeratinpositivegiantcellrichsofttissuetumors AT stoehrrobert recurrentnovelhmga2ncor2fusionscharacterizeasubsetofkeratinpositivegiantcellrichsofttissuetumors AT ferrazzifulvia recurrentnovelhmga2ncor2fusionscharacterizeasubsetofkeratinpositivegiantcellrichsofttissuetumors AT fabianpavel recurrentnovelhmga2ncor2fusionscharacterizeasubsetofkeratinpositivegiantcellrichsofttissuetumors AT michalmichal recurrentnovelhmga2ncor2fusionscharacterizeasubsetofkeratinpositivegiantcellrichsofttissuetumors AT franchialessandro recurrentnovelhmga2ncor2fusionscharacterizeasubsetofkeratinpositivegiantcellrichsofttissuetumors AT hallerflorian recurrentnovelhmga2ncor2fusionscharacterizeasubsetofkeratinpositivegiantcellrichsofttissuetumors AT folpeandrewl recurrentnovelhmga2ncor2fusionscharacterizeasubsetofkeratinpositivegiantcellrichsofttissuetumors AT kosemehmetoglukemal recurrentnovelhmga2ncor2fusionscharacterizeasubsetofkeratinpositivegiantcellrichsofttissuetumors |